US Patent Issued to Hemanext on Oct. 21 for "Methods for managing adverse events in patients with inflammation" (Illinois, New York, Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,447,177, issued on Oct. 21, was assigned to Hemanext Inc. (Lexington, Mass.).

"Methods for managing adverse events in patients with inflammation" was invented by Andrew Dunham (Tower Lakes, Ill.), Tatsuro Yoshida (West Newton, Mass.) and Samuel O. Sowemimo-Coker (Dix Hills, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for prevention and reversal of inflammation."

The patent was filed on Nov. 14, 2019, under Application No. 17/292,597.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AN...